Adv. Oded Har-Even and Howard Berkenblit assisted the Big Data company in raising $ 20 million on the Nasdaq. The firm's US Capital Markets Department represents a large numberof Israeli companies listed on the NASDAQ.
Calcalist, Dec. 13,2017
The international department team accompanied Pluristem to raise money on the Tel Aviv Stock Exchange by selling shares listed on Nasdaq. For article in Hebrew press
Advocates Shy Baranov, Itamar Mei-Zahav and Boaz Shiffman of our Tel Aviv office, and Advocates Mitchell C. Stein, Howard Berkenblit and Douglas Stransky from our US office, accompanied the company, which is currently a registered company in Israel and traded on .NASDAQ, with novel technologies based on ribonucleic acid (RNA).
The Intl legal team followed the investment process through the various stages. Colospan is a start-up company that develops innovative products in the area of colorectal surgery. The company's flagship product is designed to solve one of the common problems in colorectal surgery which is the leakage of connections after resection. The current round of financing includes rounds in which the company raised $ 4.7 million.
Adv. Oded Har-Even and Reut Alfiah accompanied the company through the double registration process.
The company is also traded on NASDAQ and is accompanied by the firm's offices in the US.
The team who represented Medigus included attorneys: Oded Har- Even, Robert Condon, Ron Ben Bassat and Hila Nahum.The Investment bank Rodman & Renshaw acted as the leading placement agent in this transaction.
The firm represented Dario in an additional finance round. The team of attorneys included Oded Har -Even, Ron Ben Basat, Robert Condon, Hila Nahum and Noa Weyl.
Therapix is a specialty clinical-stage pharmaceutical company focused on technologies and assets based on cannabinoid pharmaceuticals.
ZAG-S&W Intl team headed by Oded Har-Even & Howard Berkenblit along with attorneys: Ron Ben-Bassat, Shy Baranov, Eran Ben-Dor & Hila Barzelay-Nahum led Pluristem Therapeutics to a public offering of its common stock and warrants.
Attorneys Eran Ben-Dor & Reut Alfiah consulted the company throughout the process to recieve the Capital funding .
Attornyes Eran Ben-Dor and Lital Slutzky represented the company.
Hadasit Bio-Holdings Ltd serves as a precedent in biotechnology financing for the first time, public investment is allowed to participate in companies based on IP generated by Israel's foremost medical research center - the Hadassah University Hospital which is responsible for the majority of Israel's hospital-based research.
Attornyes Oded Har-Even, Ron Ben-Bassat and Robert Condon represented DarioHealth Corp. in the private placement.
The deal was led by OurCrowd Qure, a dedicated digital health fund.
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $12.4 million private placement offering of preferred shares By Rennova Health Inc.
Attornyes Oded Har-Even, Rob Condon and Hila Nahum represented Roth Capital.
Attorney Oded Har-Even represented Roth Capital in a $5 million private placement of Top Image System.
Attorneys Eran Ben Dor and Lital Slutzky represented the company.
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
The team includud Oded Har-Even, Robert Condon, Ron Ben Bassat and Leigh Sapir-Kashi. Roth Capital Partners acted as the lead placement agent and Maxim Group LLC acted as the co-placement agent for this transaction.
Attorneys Eran Ben-Dor and Reut Alfia, represented the company's successful fund raising of a total of $6 million.
Attorneys Eran Ben-Dor and Reut Alfia represented the company in the financing round.
the team represented the company in the Negotiation and drafted the investment transaction documents.
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.
Attorneys Oded Har-Even, Rob Condon, Hila Nahum, Jene Schlack and Ron Ben-Bassat, represented Joseph Gunnar & Co who served as an underwriter in the offering.
Adv. Ifat Nir Katz represented the company in the transaction worth $9 million.
Attorneys Oded Har-Even, Shy Baranov, Rob Condon, David Huberman and Ron Ben-Bassat, represented Renshaw & Rodman.
Adv. Eran Ben-Dor represented the Swedish company EasyPark in the transaction.
Attorneys Oded Har Even, Howard Berkenblit and David Huberman represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.
KIDOZ is a global network helping millions of kids safely play games and watch videos online.
The money was raised from private investors.
Attornyes Eran Ben-Dor and Reut Alfia represented the company.
Attornyes Oded Har-Even, Howard Berkenblit, Rob Condon and David Huberman represented the company. Mazor Robotics Ltd. is traded on the TASE and NASDAQ.
Adv. Mor Limanovich represented the company.
Attorneys Oded Har-Even, Rob Condon and Hila Nahum represented the Bank on a public offdering of VistaGen Therapeutics, a biomed company that develops products for the treatment of diseases related to the nervous system.
At the financing round participated Catalyst CEL, Autodesk and former investors from previous financing rounds.
Attornyes Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer's counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.
Attorneys Gal Chet, Gil Lavron and Nathalie Raccah represented the company in the private placement
Raziel Therapeutics has developed technology enabling to dissolve fats in the human body through injections.
The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company’s board of directors, as well as other existing shareholders.
Nano Dimension Ltd. (NNDM), a leader in the area of 3D printed electronics, uplisted its American Depositary Shares (ADSs) to the NASDAQ Capital Market under the symbol “NNDM,” effective on March 7, 2016. Nano Dimension’s ordinary shares also trade on the Tel Aviv Stock Exchange.
NSLComm in an Israeli start up which focuses on satellite communication.
Aegis Capital Corp. is an investment bank and underwriter. Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market.
Attornyes Eran Ben-Dor and Reut Alfia acted as legal counsel of the controlling shareholders of the company in a Tender Offer under Section 336 of the Israeli Company's act, which was aimed to privatize the company.
Attorneys Eran Ben-Dor and Reut Alfia represented the company. This is the company's 3rd financing in 2015.
Adv. Eran Ben-Dor represented the company in the financing round.
Attorneys Oded Har-Even, Shy Baranov, Howard Berkenblit, David Huberman and Hila Nahum represented Alcobra Pharma as issuer's counsel in an Underwritten Public Offering of approximately aggregate offering price of $42M. Jefferies LLC and Barclays Capital Inc. acted as joint book-running managers for the offering.
Attornyes Mor Limanovich and Marie Orlovsky provided the company with comprehensive legal assistance in its recent financing round, in the share purchase agreement with Magma Venture Capital IV L.P. and Magma Venture Capital IV CEO Fund L.P.
Attorneys Mor Limanovitz and Marie Orlovski represented the company in afinancing transaction (second round of financing) of $15 million. The round was led by venture capital firm Sequoia Capital and existing investor TPY Capital.
The second largest Medical Corporation in China, will receive exclusive marketing rights in the country. Endospan is an Israeli medical device company developing innovative implants for the treatment of the aorta.
Attorneys Eran Ben-Dor and Reut Alfia represented the company.
The team who lead the offering includes Oded Har-Even, Shy Baranov, Howard Berkenblit and Adi Osovsky. Maxim Group LLC acted as lead placement agent for the offering.
Attorneys Oded Har-Even and Howard Berkenblit from our U.S. Capital Markets department, represented the company in it's acquisition by Francisco Partners L.P in an amount of $438 million.
Adv. Mor Limanovich represented the company in another financing round from it's current investors.
Attornyes Eran Ben-Dor and Reut Alfiah, represented the private placement of Epoch Partner Investment Ltd., in IceCure Medical Ltd. ina total amount of $5.5 million of shares and warrants. Our firm represented both parties of the transaction.
The firm represented Alcobra in an additional public offering of $29.9 million.
Adv. Mor Limanovich represented the start-up company Coloright, which was founded in 2002 by Mr. Benny Landa, in the agreement.